Press releases & Latest news
Arfolitixorin is presented as one of the most promising pipeline drugs in the new CRC report by Global Data
Global Data recently published an outlook for the CRC market between 2018 and 2028 for the 8 major markets (8MM),…
Empowered patient podcast
Our CEO, Dr. Ulf Jungnelius, was featured on Karen Jagoda’s empowered patient podcast to discuss colorectal cancer and how our…
Presentation and poster at ASCO Gastrointestinal Cancers Symposium
Isofol is attending the event and will present details in the ongoing global Phase 3 AGENT clinical study (ISO-CC-007) Presentation…
Pharma’s Almanac – Round table
Our CEO, Anders Rabbe, was featured twice in Pharma’s Almanac Q3 issue in its “Round table” segment. He discussed the…